Clinical Failures of Linezolid and Implications for the Clinical Microbiology Laboratory
Open Access
- 1 December 2002
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (12) , 1519-1520
- https://doi.org/10.3201/eid0812.020139
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faeciumNew England Journal of Medicine, 2002
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingChest, 2000
- Successful Treatment of Vertebral Osteomyelitis with Linezolid in a Patient Receiving Hemodialysis and with Persistent Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus BacteremiasClinical Infectious Diseases, 2000
- Use of Linezolid, an Oxazolidinone, in the Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsClinical Infectious Diseases, 2000
- The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infectionJournal of Internal Medicine, 1998
- Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faeciumClinical Infectious Diseases, 1996